Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-31

Clinical Trial Update: Magnesium-Based Trigger Point Injections for Relief of Chronic Myofascial Pelvic Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating magnesium-based trigger point injections for chronic myofascial pelvic pain; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • magnesium-based trigger point injections

Snippet

Sponsor: Queen's University | Conditions: Pelvic Pain | Phase 3 | Status: TERMINATED